Italy's New Govt to Lower E-Cigarette Tax in Budget

Dec.09.2022
Italy's New Govt to Lower E-Cigarette Tax in Budget
Italy's new Meloni government plans to reduce taxes on e-cigarette liquid, providing relief for users and suppliers.

The new Meloni government in Italy has directly included a reduction in the consumption tax on e-cigarette liquid in the budget law. In fact, starting from January 2023, the tax on e-cigarette liquid will double due to the previous Conte government passing the budget law. For the uninitiated, all liquids intended for inhalation, whether containing nicotine or not, that are suitable for use with e-cigarettes are subject to appropriate consumption taxes just like traditional cigarettes as they belong to the national monopoly.


In summary, it appears that the price of e-cigarette liquid will remain steady starting in January. This will allow hundreds of thousands of Italian e-cigarette users to continue the habit of quitting smoking at a very low monthly cost. In fact, e-cigarettes have become an effective method for quitting smoking. Thanks to the new budget law, there will be no maximum increase (although the tax imposed on each bottle of alcohol will double), and the final decision will be made by the national accounting department. However, predictions are not just positive, but seem to be on the cover of everything. In short, this is good news for all participants in the e-cigarette supply chain, from e-liquid producers to retailers and end consumers, all of whom can breathe a sigh of relief. For some time now, e-cigarette retailers and manufacturers have been expecting news like this. Having a "fixed" tax that does not increase every year can allow you to expand production, distribution, and sales networks, increase job opportunities, and provide an effective tool to fight traditional smoking for more and more people.


After being sent to Brussels, the text of the budget law will be reviewed by the parliament and may be subject to modifications. However, statements from the government and armored figures from the parliament seem to ensure the certainty that Article 28 will not be altered. The same article also stipulates a slight increase in consumer tax on traditional tobacco (which actually occurs annually) in order to make up for the reduced tax on electronic and heated tobacco, which are considered lower-risk products. Assessing the current situation, the government has seemingly sent an important signal to the world of electronic cigarettes, an industry that employs tens of thousands in Italy.


In short, this is good news for loyal customers who use DEA flavored liquids, which are fully manufactured in Trento, Italy by one of the major players in the industry. Best-selling products under the DEA brand such as DEA Calliope, DEA Venere, DEA Nemesi, DEA Cuba liquids, and all other DEA brands will maintain their current prices next year.


Even DIY electronic cigarette enthusiasts stick to the concentrated flavors and neutral base they are accustomed to using. The infamous nicotine bristle remains the best-selling item in specialty stores and will maintain its price. These bristles are typically made up of just three components (propylene glycol, vegetable glycerin, and precise levels of nicotine chosen by the consumer) and play an important role for those who prefer to make their own liquid using certified and compliant products. Concentrated flavorings, like common food flavorings used for candies and cookies, are excluded from the national monopoly consumption tax. The vital first step taken by Meloni's government is hoped to provide a lifeline for the increasing number of citizens at present.


2FIRSTS will continue to follow and report on this issue, with further updates available on our app '2FIRSTSAPP.' Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | VELO Launches Tomorrowland Limited Edition 2026 as Festival IP Enters Nicotine Pouch Packaging
Product | VELO Launches Tomorrowland Limited Edition 2026 as Festival IP Enters Nicotine Pouch Packaging
BAT’s nicotine pouch brand VELO has introduced the Tomorrowland Limited Edition 2026. Public retail-channel information shows the product has appeared across multiple European online platforms, while Haypp UK has listed related SKUs with a “Coming soon” status. The packaging carries the wording “Official Tomorrowland Partner,” indicating that the collection is part of VELO’s official collaboration with the electronic music festival brand.
Jul.02
Special Report | Russia, Ukraine and Belarus Launch Fresh Push to Rein in Vaping
Special Report | Russia, Ukraine and Belarus Launch Fresh Push to Rein in Vaping
Russia, Ukraine and Belarus are tightening vape regulation through different tools, from Ukraine’s stronger enforcement push and Belarus’s proposed advertising restrictions to Russia’s new GOST standard and regional sales-ban mechanism. As black-market concerns persist, some Russian experts argue that China’s tightly controlled but legalised model — built around licensing, traceability and taxation — may offer a more effective alternative to blanket prohibition.
Jul.15
How AI Is Rewriting the Talent Playbook for the Nicotine Industry: JTI’s Case
How AI Is Rewriting the Talent Playbook for the Nicotine Industry: JTI’s Case
AI is moving from a back-office tool to a core organizational capability in the nicotine industry. Based on JTI’s responses, this 2Firsts feature examines how AI is reshaping talent strategy, internal mobility, decision-making and human accountability as global tobacco companies compete in the shift toward new nicotine categories.
Jun.17
French Vape Market Under Pressure as Europe’s First Listed Vape Company Kumulus Vape Reports 7.8% H1 Revenue Decline, Retail Sales Rise 41.5%
French Vape Market Under Pressure as Europe’s First Listed Vape Company Kumulus Vape Reports 7.8% H1 Revenue Decline, Retail Sales Rise 41.5%
Kumulus Vape, Europe’s first publicly listed vape company, reported a 7.8% year-on-year decline in first-half 2026 revenue. Amid changing conditions in France’s vape market, the company said channel diversification helped offset pressure, with physical store sales increasing 41.5% year on year. Listed on Euronext Access Paris in 2019 and later transferred to Euronext Growth Paris, Kumulus Vape is viewed as a representative company of Europe’s vape sector. Its performance highlights the industry’s shift from rapid expansion toward more operationally focused growth.
Jul.27
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.
Regulations
Jul.27
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05